MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

27 Aug 2024

Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative...

Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements

TIME names Sprout Pharmaceuticals, the maker of Addyi (flibanserin), among the 10 most influential health and life science companies of 2026

Merck’s once-daily IDVYNSO™ (doravirine/islatravir) receives FDA approval

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

By Spectrum Science
Spectrum Science
08 Jul 2026

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

By Omega Laboratories, Inc.
Omega Laboratories, Inc.
08 Jul 2026

Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

By Organon
Organon
07 Jul 2026

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

By AbbVie
AbbVie
06 Jul 2026

Nnamdi Njoku Named President of Omnicell

By Omnicell, Inc.
Omnicell, Inc.
01 Jul 2026

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

By Novo Nordisk
Novo Nordisk
01 Jul 2026

The Digital Pharma Advances Conference 2026

Most Popular

$Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.$

Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.

By Johnson & Johnson

Mar 06
Signaling exciting growth, Modular Devices welcomes Jason Thompson and Stephanie Powers Kurtz to the Cleanrooms Sales Team

By Modular Devices

Jan 14
TIME names Sprout Pharmaceuticals, the maker of Addyi (flibanserin), among the 10 most influential health and life science companies of 2026

By Sprout Pharmaceuticals

Apr 30

July 2026

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements

TIME names Sprout Pharmaceuticals, the maker of Addyi (flibanserin), among the 10 most influential health and life science companies of 2026

Merck’s once-daily IDVYNSO™ (doravirine/islatravir) receives FDA approval

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

Nnamdi Njoku Named President of Omnicell

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Most Popular

Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.

Signaling exciting growth, Modular Devices welcomes Jason Thompson and Stephanie Powers Kurtz to the Cleanrooms Sales Team

TIME names Sprout Pharmaceuticals, the maker of Addyi (flibanserin), among the 10 most influential health and life science companies of 2026

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter